Vanhala Ville, Surakka Outi, Multisilta Vilma, Lundsby Johansen Mette, Villinger Jonas, Nicolle Emmanuelle, Heikkilä Johanna, Korhonen Pentti
Tampere Heart Hospital, Elämänaukio 1, Tampere, 33520, Finland, 358 3311716.
Jamk University of Applied Sciences, Jyväskylä, Finland.
JMIR Cardio. 2025 Mar 21;9:e67774. doi: 10.2196/67774.
The insertable cardiac monitor (ICM) clinical pathway in Tampere Heart Hospital, Finland, did not correspond to the diagnostic needs of the population. There has been growing evidence of delegating the insertion from cardiologists to specially trained nurses and outsourcing the remote follow-up. However, it is unclear if the change in the clinical pathway is safe and improves efficiency.
We aim to describe and assess the efficiency of the change in the ICM clinical pathway.
Pathway improvements included initiating nurse-performed insertions, relocating the procedure from the catheterization laboratory to a procedure room, and outsourcing part of the remote follow-up to manage ICM workload. Data were collected from electronic health records of all patients who received an ICM in the Tampere Heart Hospital in 2018 and 2020. Follow-up time was 36 months after insertion.
The number of inserted ICMs doubled from 74 in 2018 to 159 in 2020. In 2018, cardiologists completed all insertions, while in 2020, a total of 70.4% (n=112) were completed by nurses. The waiting time from referral to procedure was significantly shorter in 2020 (mean 36, SD 27.7 days) compared with 2018 (mean 49, SD 37.3 days; P=.02). The scheduled ICM procedure time decreased from 60 minutes in 2018 to 45 minutes in 2020. Insertions performed in the catheterization laboratory decreased significantly (n=14, 18.9% in 2018 and n=3, 1.9% in 2020; P=<.001). Patients receiving an ICM after syncope increased from 71 to 94 patients. Stroke and transient ischemic attack as an indication increased substantially from 2018 to 2020 (2 and 62 patients, respectively). In 2018, nurses analyzed all remote transmissions. In 2020, the external monitoring service escalated only 11.2% (204/1817) of the transmissions to the clinic for revision. This saved 296 hours of nursing time in 2020. Having nurses insert ICMs in 2020 saved 48 hours of physicians' time and the shorter scheduling for the procedure saved an additional 40 hours of nursing time compared with the process in 2018. Additionally, the catheterization laboratory was released for other procedures (27 h/y). The complication rate did not change significantly (n=2, 2.7% in 2018 and n=5, 3.1% in 2020; P=.85). The 36-month diagnostic yield for syncope remained high in 2018 and 2020 (n=32, 45.1% and n=36, 38.3%; P=.38). The diagnostic yield for patients who had stroke with a procedure in 2020 was 43.5% (n=27).
The efficiency of the clinical pathway for patients eligible for an ICM insertation can be increased significantly by shifting to nurse-led insertions in procedure rooms and to the use of an external monitoring and triaging service.
芬兰坦佩雷心脏医院的植入式心脏监测器(ICM)临床路径不符合人群的诊断需求。越来越多的证据表明,可将植入工作从心脏病专家委托给经过专门培训的护士,并将远程随访外包。然而,尚不清楚临床路径的改变是否安全并能提高效率。
我们旨在描述和评估ICM临床路径改变的效率。
路径改进措施包括启动由护士进行的植入操作、将该程序从导管室转移到操作室,以及外包部分远程随访以管理ICM工作量。从2018年和2020年在坦佩雷心脏医院接受ICM的所有患者的电子健康记录中收集数据。随访时间为植入后36个月。
植入的ICM数量从2018年的74台增加了一倍,到2020年达到159台。2018年,所有植入操作均由心脏病专家完成,而2020年,共有70.4%(n = 112)由护士完成。与2018年(平均49天,标准差37.3天)相比,2020年从转诊到手术的等待时间显著缩短(平均36天,标准差27.7天;P = 0.02)。预定的ICM手术时间从2018年的60分钟减少到2020年的45分钟。在导管室进行的植入操作显著减少(2018年为14例,占18.9%;2020年为3例,占1.9%;P < 0.001)。晕厥后接受ICM的患者从71例增加到94例。作为适应症的中风和短暂性脑缺血发作从2018年到2020年大幅增加(分别为2例和62例)。2018年,护士分析所有远程传输数据。2020年,外部监测服务仅将11.2%(204/共1817例)的传输数据提交到诊所进行复查。这在2020年节省了296小时的护理时间。与2018年的流程相比,2020年由护士植入ICM节省了48小时的医生时间,并且手术安排时间缩短又节省了40小时的护理时间。此外,导管室得以腾出来用于其他手术(每年27小时)。并发症发生率没有显著变化(2018年为2例,占2.7%;2020年为5例,占3.1%;P = 0.85)。2018年和2020年晕厥的36个月诊断率仍然很高(分别为32例,占45.1%和36例,占38.3%;P = 0.38)。2020年因中风接受手术的患者的诊断率为43.5%(n = 27)。
对于符合ICM植入条件的患者,通过转向由护士在操作室进行植入以及使用外部监测和分诊服务,可显著提高临床路径的效率。